UniProt ID | FAF1_HUMAN | |
---|---|---|
UniProt AC | Q9UNN5 | |
Protein Name | FAS-associated factor 1 | |
Gene Name | FAF1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 650 | |
Subcellular Localization | Nucleus . | |
Protein Description | Ubiquitin-binding protein. [PubMed: 19722279 Required for the progression of DNA replication forks by targeting DNA replication licensing factor CDT1 for degradation] | |
Protein Sequence | MASNMDREMILADFQACTGIENIDEAITLLEQNNWDLVAAINGVIPQENGILQSEYGGETIPGPAFNPASHPASAPTSSSSSAFRPVMPSRQIVERQPRMLDFRVEYRDRNVDVVLEDTCTVGEIKQILENELQIPVSKMLLKGWKTGDVEDSTVLKSLHLPKNNSLYVLTPDLPPPSSSSHAGALQESLNQNFMLIITHREVQREYNLNFSGSSTIQEVKRNVYDLTSIPVRHQLWEGWPTSATDDSMCLAESGLSYPCHRLTVGRRSSPAQTREQSEEQITDVHMVSDSDGDDFEDATEFGVDDGEVFGMASSALRKSPMMPENAENEGDALLQFTAEFSSRYGDCHPVFFIGSLEAAFQEAFYVKARDRKLLAIYLHHDESVLTNVFCSQMLCAESIVSYLSQNFITWAWDLTKDSNRARFLTMCNRHFGSVVAQTIRTQKTDQFPLFLIIMGKRSSNEVLNVIQGNTTVDELMMRLMAAMEIFTAQQQEDIKDEDEREARENVKREQDEAYRLSLEADRAKREAHEREMAEQFRLEQIRKEQEEEREAIRLSLEQALPPEPKEENAEPVSKLRIRTPSGEFLERRFLASNKLQIVFDFVASKGFPWDEYKLLSTFPRRDVTQLDPNKSLLEVKLFPQETLFLEAKE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
30 | Ubiquitination | IDEAITLLEQNNWDL HHHHHHHHHHCCHHH | 4.81 | 23000965 | |
34 | Ubiquitination | ITLLEQNNWDLVAAI HHHHHHCCHHHHHHH | 33.08 | 21890473 | |
37 | Ubiquitination | LEQNNWDLVAAINGV HHHCCHHHHHHHCCC | 1.82 | 23000965 | |
48 | Ubiquitination | INGVIPQENGILQSE HCCCCCCCCCCEEEC | 52.66 | 23000965 | |
54 | Ubiquitination | QENGILQSEYGGETI CCCCCEEECCCCCCC | 29.37 | 23000965 | |
70 | O-linked_Glycosylation | GPAFNPASHPASAPT CCCCCCCCCCCCCCC | 31.12 | 23301498 | |
80 | O-linked_Glycosylation | ASAPTSSSSSAFRPV CCCCCCCCCCCCCCC | 28.25 | 23301498 | |
112 | Ubiquitination | VEYRDRNVDVVLEDT EEECCCCCCEEEECC | 6.52 | 21890473 | |
120 | Glutathionylation | DVVLEDTCTVGEIKQ CEEEECCCCHHHHHH | 4.49 | 22555962 | |
138 | Phosphorylation | NELQIPVSKMLLKGW CCCCCCHHHHHHCCC | 13.64 | 30622161 | |
139 (in isoform 1) | Ubiquitination | - | 33.53 | 21890473 | |
139 (in isoform 2) | Ubiquitination | - | 33.53 | 21890473 | |
139 | Ubiquitination | ELQIPVSKMLLKGWK CCCCCHHHHHHCCCC | 33.53 | 21890473 | |
139 | Ubiquitination | ELQIPVSKMLLKGWK CCCCCHHHHHHCCCC | 33.53 | 23000965 | |
143 (in isoform 1) | Ubiquitination | - | 59.78 | 21890473 | |
143 (in isoform 2) | Ubiquitination | - | 59.78 | 21890473 | |
143 | Ubiquitination | PVSKMLLKGWKTGDV CHHHHHHCCCCCCCC | 59.78 | 23000965 | |
143 | Ubiquitination | PVSKMLLKGWKTGDV CHHHHHHCCCCCCCC | 59.78 | 21890473 | |
143 | Acetylation | PVSKMLLKGWKTGDV CHHHHHHCCCCCCCC | 59.78 | 25953088 | |
146 | Ubiquitination | KMLLKGWKTGDVEDS HHHHCCCCCCCCCCC | 51.83 | 21890473 | |
146 | Ubiquitination | KMLLKGWKTGDVEDS HHHHCCCCCCCCCCC | 51.83 | 23000965 | |
146 | Acetylation | KMLLKGWKTGDVEDS HHHHCCCCCCCCCCC | 51.83 | 19819239 | |
146 (in isoform 1) | Ubiquitination | - | 51.83 | 21890473 | |
146 (in isoform 2) | Ubiquitination | - | 51.83 | 21890473 | |
147 | Phosphorylation | MLLKGWKTGDVEDST HHHCCCCCCCCCCCC | 31.91 | 20068231 | |
153 | Phosphorylation | KTGDVEDSTVLKSLH CCCCCCCCCCCEEEE | 13.60 | 20068231 | |
154 | Phosphorylation | TGDVEDSTVLKSLHL CCCCCCCCCCEEEEC | 42.03 | 20068231 | |
157 (in isoform 1) | Ubiquitination | - | 46.78 | 21890473 | |
157 | Malonylation | VEDSTVLKSLHLPKN CCCCCCCEEEECCCC | 46.78 | 26320211 | |
157 | Acetylation | VEDSTVLKSLHLPKN CCCCCCCEEEECCCC | 46.78 | 25953088 | |
157 | Ubiquitination | VEDSTVLKSLHLPKN CCCCCCCEEEECCCC | 46.78 | 23000965 | |
157 | Ubiquitination | VEDSTVLKSLHLPKN CCCCCCCEEEECCCC | 46.78 | 21890473 | |
157 (in isoform 2) | Ubiquitination | - | 46.78 | 21890473 | |
163 | Ubiquitination | LKSLHLPKNNSLYVL CEEEECCCCCEEEEE | 75.11 | 23000965 | |
207 | Phosphorylation | HREVQREYNLNFSGS EHHHHHHHCCCCCCC | 27.43 | 29083192 | |
212 | Phosphorylation | REYNLNFSGSSTIQE HHHCCCCCCCHHHHH | 36.37 | 25693802 | |
214 | Phosphorylation | YNLNFSGSSTIQEVK HCCCCCCCHHHHHHH | 24.10 | 25693802 | |
215 | Phosphorylation | NLNFSGSSTIQEVKR CCCCCCCHHHHHHHH | 32.81 | 25693802 | |
216 | Phosphorylation | LNFSGSSTIQEVKRN CCCCCCHHHHHHHHH | 28.51 | 25693802 | |
221 (in isoform 1) | Ubiquitination | - | 37.19 | 21890473 | |
221 | Ubiquitination | SSTIQEVKRNVYDLT CHHHHHHHHHHCCCC | 37.19 | 21890473 | |
221 | Ubiquitination | SSTIQEVKRNVYDLT CHHHHHHHHHHCCCC | 37.19 | 21963094 | |
225 | Phosphorylation | QEVKRNVYDLTSIPV HHHHHHHCCCCCCCC | 14.58 | 28152594 | |
264 | Phosphorylation | SYPCHRLTVGRRSSP CCCCEEECCCCCCCC | 22.37 | 21712546 | |
269 | Phosphorylation | RLTVGRRSSPAQTRE EECCCCCCCCCHHHH | 39.03 | 20068231 | |
270 | Phosphorylation | LTVGRRSSPAQTREQ ECCCCCCCCCHHHHC | 23.57 | 28176443 | |
274 | Phosphorylation | RRSSPAQTREQSEEQ CCCCCCHHHHCCHHH | 37.98 | 20068231 | |
289 | Phosphorylation | ITDVHMVSDSDGDDF CCEEEEEECCCCCCH | 24.67 | 11713579 | |
291 | Phosphorylation | DVHMVSDSDGDDFED EEEEEECCCCCCHHH | 35.67 | 11713579 | |
292 (in isoform 2) | Ubiquitination | - | 70.32 | 21890473 | |
305 (in isoform 2) | Ubiquitination | - | 59.59 | 21890473 | |
314 | Phosphorylation | GEVFGMASSALRKSP HHHEEECCHHHHCCC | 13.78 | 26074081 | |
315 | Phosphorylation | EVFGMASSALRKSPM HHEEECCHHHHCCCC | 23.06 | 26074081 | |
319 | Ubiquitination | MASSALRKSPMMPEN ECCHHHHCCCCCCCC | 60.81 | - | |
320 | Phosphorylation | ASSALRKSPMMPENA CCHHHHCCCCCCCCC | 16.17 | 30278072 | |
335 | Ubiquitination | ENEGDALLQFTAEFS CCCCCHHHHHHHHHH | 4.16 | 22817900 | |
342 | Phosphorylation | LQFTAEFSSRYGDCH HHHHHHHHHHHCCCE | 12.86 | - | |
343 | Phosphorylation | QFTAEFSSRYGDCHP HHHHHHHHHHCCCEE | 34.54 | - | |
348 | Ubiquitination | FSSRYGDCHPVFFIG HHHHHCCCEEEEEEE | 3.20 | 22053931 | |
434 | Phosphorylation | MCNRHFGSVVAQTIR HHHHHHHHHHHHHHH | 16.69 | 24043423 | |
439 | Phosphorylation | FGSVVAQTIRTQKTD HHHHHHHHHHCCCCC | 11.59 | 24043423 | |
442 | Phosphorylation | VVAQTIRTQKTDQFP HHHHHHHCCCCCCCC | 30.48 | 24043423 | |
444 (in isoform 1) | Ubiquitination | - | 54.15 | 21890473 | |
444 | Ubiquitination | AQTIRTQKTDQFPLF HHHHHCCCCCCCCEE | 54.15 | 21906983 | |
445 | Phosphorylation | QTIRTQKTDQFPLFL HHHHCCCCCCCCEEE | 25.80 | 24043423 | |
457 | Ubiquitination | LFLIIMGKRSSNEVL EEEEEEECCCHHHHH | 31.55 | 20639865 | |
457 (in isoform 1) | Ubiquitination | - | 31.55 | 21890473 | |
496 | Ubiquitination | AQQQEDIKDEDEREA HHHHHHCCCHHHHHH | 68.34 | 29901268 | |
508 | Sumoylation | REARENVKREQDEAY HHHHHHHHHHHHHHH | 62.90 | - | |
518 | Phosphorylation | QDEAYRLSLEADRAK HHHHHHHHHHHHHHH | 18.37 | 28555341 | |
544 | Ubiquitination | FRLEQIRKEQEEERE HCHHHHHHHHHHHHH | 66.43 | - | |
556 | Phosphorylation | EREAIRLSLEQALPP HHHHHHHHHHHHCCC | 21.73 | 25159151 | |
566 | Ubiquitination | QALPPEPKEENAEPV HHCCCCCCCCCCCCC | 75.81 | 24816145 | |
575 | Ubiquitination | ENAEPVSKLRIRTPS CCCCCCCCCEEECCC | 41.86 | 29901268 | |
580 | Phosphorylation | VSKLRIRTPSGEFLE CCCCEEECCCHHHHH | 21.31 | 23401153 | |
582 | Phosphorylation | KLRIRTPSGEFLERR CCEEECCCHHHHHHH | 50.79 | 19664994 | |
631 | Ubiquitination | VTQLDPNKSLLEVKL CCCCCCCCCCEEEEE | 48.12 | 29967540 | |
637 | Ubiquitination | NKSLLEVKLFPQETL CCCCEEEEECCCCCE | 34.73 | 32015554 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
289 | S | Phosphorylation | Kinase | AURKA | O14965 | GPS |
289 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
289 | S | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
289 | S | Phosphorylation | Kinase | CK2_GROUP | - | PhosphoELM |
291 | S | Phosphorylation | Kinase | AURKA | O14965 | GPS |
291 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
291 | S | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
291 | S | Phosphorylation | Kinase | CK2_GROUP | - | PhosphoELM |
556 | S | Phosphorylation | Kinase | IKKE | Q14164 | PSP |
582 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | PRKN | O60260 | PMID:23307929 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FAF1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FAF1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320 AND SER-582, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-225, AND MASSSPECTROMETRY. |